Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
ExcellGene SA logo — We are a CDMO providing Swiss quality cell line development...

ExcellGene SA

We are a CDMO providing Swiss quality cell line development and protein expression services. Expect Great Science.

Founded 2001 Switzerland Monthey, Switzerland 64 employees Biotechnology, Information Technology

General Information

Company Name ExcellGene SA
Founded Year 2001
Location Switzerland Monthey, Switzerland
Employees 64
Industries Biotechnology, Information Technology
Social

BounceWatch is an independent company data service, not affiliated with ExcellGene SA. To contact ExcellGene SA, visit excellgene.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does ExcellGene SA compare?

A PDF of ExcellGene SA and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting ExcellGene SA soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About ExcellGene SA

ExcellGene SA is a Swiss CDMO (Contract Development and Manufacturing Organization) renowned for its superior cell line development and protein expression services. Established in 2001, the company has over two decades of expertise in biotechnology and information technology sectors.

Specializing in CHO and HEK293 cell lines, ExcellGene offers high-yielding solutions ready for GMP production, pivotal for biologics, biosimilars, and gene therapies. The company demonstrates a versatile capability to express a variety of proteins, including bi-specific monoclonal antibodies, Fc-fusions, and viral proteins, ensuring comprehensive support from process development through to master cell banking.

Located in Switzerland, the firm emphasizes a commitment to quality and customer satisfaction. Recently, ExcellGene garnered attention with a buyout investment from ArchiMed dated 01 September 2025, reflecting strong investor confidence and growth potential within the biotech landscape.

Business keywords: CDMO, Cell Line Development, Protein Expression Services, Biologics Production, Biosimilars, Gene Therapy, CHO Cell Lines, HEK293 Cell Lines, AAV Production, Master Cell Banking, GMP Compliance, Scale-Up Processes, Process Development, Stable Protein Expression, Transient Protein Expression

Services & Products

CHO and HEK293 cell line development
Recombinant biologics manufacturing
Process development for upstream and downstream
Comprehensive cell banking services
Biosimilar cell line and process development

Target Customers

Biotechnology companies Pharmaceutical companies Biopharmaceutical research organizations

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Buyout Undisclosed 1
ArchiMed
ArchiMed
01 Sep 2025
Spinout Undisclosed 1
EPFL Swiss Federal Institute of Technology in Lausanne
01 Oct 2001

ExcellGene SA Alternatives & Competitors

View All Alternatives
ExcellGene SA vs
MIRCOD LLC
MIRCOD LLC United States

Our mission is to create innovative products and services in the IoT, IOMT, BioTech, and Healthcare...

Seed
45 employees
AI, Biotechnology
ExcellGene SA vs
Form Bio
Form Bio

Leading provider of AI-powered solutions for genetic medicine and genome engineering.

36 employees
Biotechnology, Data Analytics
ExcellGene SA vs
StrideBio, Inc
StrideBio, Inc United States

The next evolution in gene therapy

Acquired
4 employees
Biotechnology, Health Care
View all alternatives

FAQ About ExcellGene SA

We are a CDMO providing Swiss quality cell line development and protein expression services. Expect Great Science.
ExcellGene SA was founded in 2001.
ExcellGene SA is headquartered in Monthey, Switzerland.
ExcellGene SA operates in Biotechnology and Information Technology. Its work centres on CDMO, Cell Line Development, Protein Expression Services and Biologics Production. Its customers include Biotechnology companies, Pharmaceutical companies and Biopharmaceutical research organizations.
ExcellGene SA has approximately 64 employees.
ExcellGene SA has completed 2 funding rounds.
ExcellGene SA offers: CHO and HEK293 cell line development, Recombinant biologics manufacturing, Process development for upstream and downstream, Comprehensive cell banking services, Biosimilar cell line and process development.
Top alternatives and competitors to ExcellGene SA include MIRCOD LLC, Form Bio, StrideBio, Inc. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
ExcellGene SA and MIRCOD LLC are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for ExcellGene SA, https://bouncewatch.com/company/excellgene-sa, updated 26 September 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes